Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Adobe
ADBE
|
+$593M |
| 2 |
Tesla
TSLA
|
+$473M |
| 3 |
Nike
NKE
|
+$403M |
| 4 |
AstraZeneca
AZN
|
+$401M |
| 5 |
Airbnb
ABNB
|
+$347M |
Top Sells
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$457M |
| 4 |
Aon
AON
|
+$410M |
| 5 |
Apple
AAPL
|
+$401M |
Sector Composition
| 1 | Technology | 20.43% |
| 2 | Healthcare | 20.23% |
| 3 | Consumer Staples | 11.18% |
| 4 | Consumer Discretionary | 9.83% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NMRD
2876
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $520K | ﹤0.01% |
86,500
+57,674
| +200% | +$347K |
|
|
CLVS
2877
DELISTED
Clovis Oncology, Inc.
CLVS
| $520K | ﹤0.01% |
+116,700
| New | +$520K |
|
2878
iShares Global 100 ETF
IOO
$7.17B
| $519K | ﹤0.01% |
+7,300
| New | +$519K |
|
2879
Shinhan Financial Group
SHG
$24B
| $512K | ﹤0.01% |
+15,200
| New | +$512K |
|
2880
Afya
AFYA
$1.42B
| $511K | ﹤0.01% |
25,900
+8,600
| +50% | +$170K |
|
2881
Digi International
DGII
$1.33B
| $509K | ﹤0.01% |
24,200
-83,721
| -78% | -$1.76M |
|
|
SELF
2882
Global Self Storage
SELF
$58.4M
| $509K | ﹤0.01% |
98,900
+25,700
| +35% | +$132K |
|
2883
XPEL
XPEL
$960M
| $508K | ﹤0.01% |
6,700
-16,400
| -71% | -$1.24M |
|
|
FNCB
2884
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $508K | ﹤0.01% |
61,718
-31,882
| -34% | -$262K |
|
2885
Targa Resources
TRGP
$35.8B
| $507K | ﹤0.01% |
+10,300
| New | +$507K |
|
2886
Pliant Therapeutics
PLRX
$97.6M
| $506K | ﹤0.01% |
+30,000
| New | +$506K |
|
2887
Sonoma Pharmaceuticals
SNOA
$7.35M
| $506K | ﹤0.01% |
4,533
-75
| -2% | -$8.37K |
|
2888
John Wiley & Sons Class A
WLY
$2.19B
| $506K | ﹤0.01% |
+9,700
| New | +$506K |
|
2889
Simmons First National
SFNC
$2.96B
| $505K | ﹤0.01% |
+17,088
| New | +$505K |
|
2890
Business First Bancshares
BFST
$723M
| $503K | ﹤0.01% |
21,500
-600
| -3% | -$14K |
|
|
BSCL
2891
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
| $503K | ﹤0.01% |
23,845
-204,749
| -90% | -$4.32M |
|
2892
Nuvation Bio
NUVB
$1.07B
| $501K | ﹤0.01% |
50,400
-416,400
| -89% | -$4.14M |
|
2893
National CineMedia
NCMI
$455M
| $500K | ﹤0.01% |
14,056
-22,550
| -62% | -$802K |
|
2894
loanDepot
LDI
$894M
| $498K | ﹤0.01% |
+73,581
| New | +$498K |
|
2895
ProShares Ultra Technology
ROM
$815M
| $497K | ﹤0.01% |
+10,000
| New | +$497K |
|
2896
Athira Pharma
ATHA
$14.2M
| $495K | ﹤0.01% |
+52,733
| New | +$495K |
|
|
VINC
2897
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $495K | ﹤0.01% |
1,530
-1,925
| -56% | -$623K |
|
2898
Sabra Healthcare REIT
SBRA
$4.57B
| $494K | ﹤0.01% |
33,580
-877,099
| -96% | -$12.9M |
|
2899
Tempest Therapeutics
TPST
$45.6M
| $493K | ﹤0.01% |
2,623
+556
| +27% | +$105K |
|
2900
FTAI Aviation
FTAI
$17.6B
| $492K | ﹤0.01% |
+22,681
| New | +$492K |
|